Live Breaking News & Updates on Pharmaceutical Europe

Stay updated with breaking news from Pharmaceutical europe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Abilify Maintena® 960 mg (aripiprazole) approved in the EU as the first once-every-two-months long-acting injectable for the maintenance treatment of

Aripiprazole’s new long-acting injectable (LAI) formulation enables continuous exposure to medication for two months1.Windsor, United Kingdom/Valby, Denmark, 27 March, 2024 – Otsuka Pharmaceutical Europe Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) today announced that the European Commission (EC) has ap. ....

Abilify Maintena , Peter Gillberg , Otsuka Europe , Johan Luthman , European Commission , Otsuka Pharmaceutical Company Ltd , Otsuka Holdings Co Ltd , Head Of Medical Affairs At Otsuka Europe , European Union , Otsuka Pharmaceutical Europe Ltd , Head Of Research Development At Lundbeck , Otsuka Pharmaceutical Europe , Executive Vice President , Vice President , Medical Affairs , Pharmaceutical Europe , Otsuka Pharmaceutical Company ,

Otsuka and Astex announce that the European Commission has approved INAQOVI® (oral decitabine and cedazuridine) for the treatment of adults with newly diagnosed acute myeloid leukaemia

Otsuka and Astex announce that the European Commission has approved INAQOVI® (oral decitabine and cedazuridine) for the treatment of adults with newly diagnosed acute myeloid leukaemia
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Otsuka Europe , Martin Buckland , Alison Ross , Otsuka Pharmaceutical Europe Ltd , Taiho Oncology Inc , Taiho Pharmaceutical Co Ltd , Otsuka Pharmaceutical Company Ltd , European Hematology Association Congress , Otsuka Holdings Co Ltd , European Commission , American Society Of Hematology Annual Meeting , European Medicines Agency , Otsuka Pharmaceutical Co Ltd , Astex Pharmaceuticals Inc , Pharmaceutical Europe , Astex Pharmaceuticals , European Economic Area , Paediatric Investigation Plan , Median Overall Survival , Complete Response , Otsuka Pharmaceutical Company , Taiho Oncology , Practice Guidelines , Therapy Extend , Cynomolgus Monkeys ,

Astex Pharmaceuticals, Inc.: Otsuka and Astex announce that the European Commission has approved INAQOVI (oral decitabine and cedazuridine) for the treatment of adults with newly diagnosed acute myeloid leukaemia

Astex Pharmaceuticals, Inc.: Otsuka and Astex announce that the European Commission has approved INAQOVI (oral decitabine and cedazuridine) for the treatment of adults with newly diagnosed acute myeloid leukaemia
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Alison Ross , Otsuka Europe , Martin Buckland , Otsuka Holdings Co Ltd , Astex Pharmaceuticals Inc , Taiho Oncology Inc , Otsuka Pharmaceutical Company Ltd , European Medicines Agency , European Hematology Association Congress , Otsuka Pharmaceutical Co Ltd , European Commission , Otsuka Pharmaceutical Europe Ltd , American Society Of Hematology Annual Meeting , Taiho Pharmaceutical Co Ltd , Otsuka Pharmaceutical Europe , Astex Pharmaceuticals , European Economic Area , Paediatric Investigation Plan , Median Overall Survival , Complete Response , Pharmaceutical Europe , Otsuka Pharmaceutical Company , Taiho Oncology , Practice Guidelines , Therapy Extend ,

Oral Decitabine and Cedazuridine Wins EU Approval for Newly Diagnosed AML

The European Commission has approved oral decitabine and cedazuridine for the treatment of adult patients with newly diagnosed acute myeloid leukemia who are ineligible for standard induction chemotherapy. ....

United States , Astex Pharamceuticals , International Congress On Myelodysplastic Syndromes , Astex Pharmaceuticals , European Commission , North America , Pharmaceutical Europe , International Congress , Newly Diagnosed Acute Myeloid Leukemia , European Commission ,

Otsuka announces NICE recommendation of Lupkynis® (voclosporin) with mycophenolate mofetil for treating active lupus nephritis

Otsuka announces NICE recommendation of Lupkynis®      (voclosporin) with mycophenolate mofetil for treating active lupus nephritis LONDON, UK, 3 May 2023 – Otsuka Pharmaceuticals (U.K.) Ltd. announces that the National Institute for Health and C. ....

Northern Ireland , United Kingdom , City Of , Great Britain , Otsuka Europe , Ryan Gynne , Paul Howard , European Union , European Commission , Otsuka Pharmaceutical Europe Ltd , Healthcare Products Regulatory Agency , Otsuka Pharmaceutical Co Ltd , Scottish Medicines Consortium , Otsuka Pharmaceutical Company Ltd , Otsuka Pharmaceuticals Uk Ltd , National Centre For Pharmacoeconomics Ireland , National Institute For Health , Otsuka Holdings Co Ltd , Otsuka Pharmaceuticals , National Institute , Care Excellence , Chief Executive , Managing Director , National Centre , Pharmacoeconomics Ireland , Pharmaceutical Europe ,